Chimerix

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Chimerix and other ETFs, options, and stocks.

About CMRX

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox.

CEO

Michael T. Andriole

CEOMichael T. Andriole

Employees

Employees72

Headquarters

Durham, North Carolina

HeadquartersDurham, North Carolina

Founded

2000

Founded2000

Employees

Employees72

CMRX Key Statistics

Market cap

758.16M

Market cap758.16M

Price-Earnings ratio

-9.05

Price-Earnings ratio-9.05

Dividend yield

—

Dividend yield—

Average volume

13.71M

Average volume13.71M

High today

$8.44

High today$8.44

Low today

$8.42

Low today$8.42

Open price

$8.43

Open price$8.43

Volume

1.09M

Volume1.09M

52 Week high

$8.47

52 Week high$8.47

52 Week low

$0.75

52 Week low$0.75

CMRX News

Benzinga 1d

Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline

On Tuesday, Jazz Pharmaceuticals plc JAZZ agreed to acquire Chimerix Inc CMRX for $8.55 per share in cash, representing a total consideration of approximately $...